Sökresultat

Using the CRISPR/Cas9 “gene scissors” researchers at Lund University Diabetes Centre in Sweden have managed to “turn off” an enzyme that proved to play a key role in the regulation of the diabetes-associated TXNIP gene. The results are decreased cell death and increased insulin production in the genetically modified pancreatic beta cells. In a recent study, researchers have conducted an investigat

https://www.ludc.lu.se/article/decreased-cell-death-and-increased-insulin-production-pancreatic-beta-cells-genome-edit-crisprcas9 - 2026-01-01

Charlotte Ling, professor of epigenetics at the Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Sweden, has been awarded the European Research Council’s Consolidator Grant. The funding of EUR 2 million over five years will be used to develop new methods to improve prediction, prevention and treatment of type 2 diabetes. Charlotte Ling is a pioneer within epigenetics and

https://www.ludc.lu.se/article/investments-epigenetics-combat-diabetes - 2026-01-01

BEAt-DKD (“Biomarker Enterprise to Attack Diabetic Kidney Disease”), a unique public private partnership funded by the Innovative Medicines Initiative (IMI), member companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Juvenile Diabetes Research Foundation (JDRF) and the state of Switzerland has announced the launch of a 5-year project (total budget 28.9

https://www.ludc.lu.se/article/beat-dkd-innovative-medicines-initiative-project-precision-medicine-dkd - 2026-01-01

In his research in zebrafish, Olov Andersson of Karolinska Institutet strives to generate insulin-producing cells and new treatment methods for diabetes. This has led to his selection as a recipient of the Leif C. Groop award for outstanding research, awarded by the Lund University Diabetes Centre and sponsored by Novo Nordisk Sweden. “It is terrific for our research to be recognised in this way,

https://www.ludc.lu.se/article/prize-awarded-research-zebrafish-could-lead-new-treatments-diabetes - 2026-01-01

A two-days seminar gathered some 70 researchers from the University of Bergen, the Institute for Molecular Medicine in Finland (FIMM) and Lund University Diabetes Centre. - We wanted to strengthen the bonds that already exist and in the future create a Nordic network of metabolic researchers, says Ola Hansson who organized the meeting. Kay Prüfer from Max-Planck Institute in Leipzig, Germany, was

https://www.ludc.lu.se/article/nordic-network-metabolic-researchers - 2026-01-01

In Skåne, newborn babies can be screened for type 1 diabetes and celiac disease (gluten intolerance). To raise awareness about the screening we will be running an information campain on all commuter trains and busses in Skåne during week 15 and 19. Children found to be at risk are eligable to participate in our prevention studies POInT or PreCiSe.More informationPI: Helena Elding Larsson

https://www.ludc.lu.se/article/screening-t1d-and-celiac-disease - 2026-01-01

The 3rd Joint EASD Islet Study Group and Beta-Cell Workshop gathered experts in islet cell biology - mainly beta cells - ranging from development to function and with a focus on both type 1- and type 2-diabetes. This year the EASD islet study group and the bi-annual beta cell workshop were merged gathering current islet cell research in one and the same meeting. Lund University Diabetes Centre was

https://www.ludc.lu.se/article/3rd-joint-easd-islet-study-group-and-beta-cell-workshop - 2026-01-01

In Skåne, newborn babies can be screened for type 1 diabetes and celiac disease (gluten intolerance). More than expected have been found to have an increased risk of developing these diseases, and about thirty children have already been recruited for research studies aimed at lowering this risk. Large-scale screening of newborn children in Skåne started in the summer of 2018 and will last until 20

https://www.ludc.lu.se/article/screening-finds-children-high-risk-type-1-diabetes-and-celiac-disease - 2026-01-01

David Nicholls, professor emeritus of Mitochondrial Physiology at the Buck Institute in Novato, California and mentor at the Lund University Diabetes Centre, has become a member of the British Royal Society. The society’s fellows include many of the world’s most eminent scientists. “I feel immensely honoured!” says David Nicholls. David Nicholls knew from a very early age that he wanted to be invo

https://www.ludc.lu.se/article/diabetes-researcher-elected-british-royal-society - 2026-01-01

In the past decade, knowledge of how lifestyle affects our genes, a research field called epigenetics, has grown exponentially. Researchers at the Lund University Diabetes Centre have summarised the state of scientific knowledge within epigenetics linked to obesity and type 2 diabetes in a review article published in the scientific journal Cell Metabolism. Epigenetic mechanisms (see fact box) cont

https://www.ludc.lu.se/article/how-lifestyle-affects-our-genes - 2026-01-01

Indian women are younger and leaner than Swedish women when they develop gestational diabetes, a new study from Lund University Diabetes Centre shows. The researchers also found a gene that increases the risk of gestational diabetes in Swedish women, but which, on the contrary, turned out to have a protective effect in Indian women. Gestational diabetes is characterized by impaired insulin product

https://www.ludc.lu.se/article/gestational-diabetes-india-and-sweden - 2026-01-01

Helena Elding Larsson, senior physician and associate professor at Lund University, has been awarded 1,1 million SEK from Odd Fellow Orden Sweden. Helena Elding Larsson has been awarded a gift as support for a research project aiming to study if oral insulin given to children from 4-7 months of age to 3 years, with high genetic risk, can prevent the development of beta cell autoantibodies and late

https://www.ludc.lu.se/article/ludc-researcher-awarded - 2026-01-01

We are now looking for a new grant manager! The grant manager has a central role in connecting different stakeholders in the environment and from this position be involved in designing diverse centre activities. The position is full-time and is limited to six months. Start as soon as possible. For more information about the position, and apply

https://www.ludc.lu.se/article/open-position-grant-manager - 2026-01-01

The company builder and patron Bo Hjelt has become honorary doctor at the Faculty of Medicine at Lund University. The doctoral conferment ceremony was held in Lund on May 24. Bo Hjelt (born 1935) was born and raised in Sweden. He studied economics in Geneva. After being employed at the metal works company, Svenska Metallverken, he started his own business which was to become the multinational comp

https://www.ludc.lu.se/article/bo-hjelt-honorary-doctor-lund-university - 2026-01-01

Register now for a free, full-day symposium in Gothenburg, Sweden, on 14 June, 2019, hosted by the Nordic Society for Human Genetics and Precision Medicine. This satellite meeting before the annual ESHG conference will feature the latest findings in discovery genetics from the Nordic countries, presented by the next wave of researchers from Denmark, Estonia, Finland, Iceland, Norway, and Sweden. W

https://www.ludc.lu.se/article/nshg-register-now - 2026-01-01

Presented on June 9 at the 2019 American Diabetes Association’s 79th Scientific Sessions and published in the New England Journal of Medicine (nejm.org), findings from TrialNet’s Teplizumab (anti-CD3) Prevention Study show a drug that targets the immune system can delay type 1 diabetes a median of 2 years in children and adults at high risk. “This is great news for millions of people worldwide imp

https://www.ludc.lu.se/article/immunotherapy-delays-type-1-diabetes-diagnosis-people-high-risk - 2026-01-01

The Swedish Society of Medicine has awarded post retirement professor Åke Lernmark at Lund University with the Oscar Medin Prize and SEK 25 000. Åke Lernmark started his research career in type 1 diabetes in the 1970s.He is responsible for the Swedish part of the TEDDY study and TrialNet, among others, in which he has studied why certain children develop type 1 diabetes while others do not.How doe

https://www.ludc.lu.se/article/ake-lernmark-awarded-his-epoch-making-contributions-children-type-1-diabetes - 2026-01-01

´Digitalization for the benefit of the diabetes patient´ är namnet på en av de fyra så kallade ”Super Sessions”, seminarieserier, vid kommande NLSDays. Det är diabetesvården som ska belysas: hur digitalisering kan förbättra den och vad läkemedelsindustrin gör inom området. Läs artikeln på Medeons blogg

https://www.ludc.lu.se/article/nlsdays-medeon-och-ludc-ar-vardar-super-session-diabetes - 2026-01-01

The role of gut microbiota in disease and health has become one of today’s hottest fields of research. In her thesis, Louise Brunkwall, nutritionist and doctoral student at Lund University in Sweden, studied overweight, obesity and the importance of diet quality in relation to our gut microbiota.  Obesity arises when the energy intake from what we eat is greater than the energy we consume. However

https://www.ludc.lu.se/article/thesis-significance-diet-quality-gut-microbiota - 2026-01-01

Jones Ofori is one of the researchers from LUDC participating in EASD in Barcelona. He will be presenting new findings on miR-200c. Learn more about him and his research here.  I am Jones Ofori and I am originally from Ghana. In 2011 I got the opportunity to pursue a master degree in Molecular biology and Biotechnology at Lund University. During the Master’s program I was privilege to do Master’s

https://www.ludc.lu.se/article/easd-micrornas-future-targets-diabetes-treatment - 2026-01-01